KevinMD October 19, 2020
Scarcity has, in many ways, defined the COVID-19 experience in the U.S., from shortages in personal protective equipment to ICU ventilators and hospital capacity, to COVID test kits, to drugs like Remdesivir in hard-hit states. These shortages have added impetus and new dimensions to existing conversations around health care supply chains, some of which had originally stemmed from a climate-conscious, sustainabil
COVID-19 illustrates the need for greater resiliency within health care’s supply chain. Dependence on expansive global networks for raw materials,...